Previous Article | Next Article 
Journal of Clinical Microbiology, July 2004, p. 3303-3305, Vol. 42, No. 7
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.7.3303-3305.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Phenotypic and Molecular Characterization of Erythromycin Resistance in Four Isolates of Streptococcus-Like Gram-Positive Cocci Causing Bacteremia
Patrick C. Y. Woo, Amanda P. C. To, Susanna K. P. Lau, Ami M. Y. Fung, and Kwok-yung Yuen*
Department of Microbiology, The University of Hong Kong, Hong Kong
Received 13 October 2003/
Returned for modification 13 January 2004/
Accepted 11 March 2004

ABSTRACT
Among nine patients with bacteremia caused by
Granulicatella or
Gemella in a 6-year period (July 1995 to June 2001), three
had bacteremia caused by erythromycin-resistant
Granulicatella adiacens and one had bacteremia caused by erythromycin-resistant
Gemella haemolysans. All four isolates possessed
mef genes,
whereas none possessed
ermT,
ermTR, or
ermB genes.

TEXT
Macrolides constitute an important group of drugs because of
their antimicrobial and immunomodulatory activities (
17). Macrolide
resistance has been increasingly reported in various species
of
Streptococcus (
5-
7,
11,
20,
21) and is mediated through two
major mechanisms, target site modification and efflux pumps.
Target site modification is mediated through the acquisition
of
erm (erythromycin resistance methylase) genes (
2-
5,
12,
13,
15,
20). These genes encode enzymes that N
6 dimethylate a specific
adenine residue in the peptidyl transferase circle of 23S rRNA
domain V of the bacteria, leading to cross-resistance to macrolides,
lincosamides, and streptogramin B. As for efflux pumps, they
are mediated through
mef genes, which encode membrane proteins
responsible for active efflux of macrolides, hence reducing
the intracellular macrolide concentration to subtoxic levels.
No study describing the phenotypic and molecular characterization of macrolide resistance in Streptococcus-like gram-positive cocci (Granulicatella and Gemella) was found in the literature. In this study, we report phenotypic and genotypic characterization of the erythromycin resistance in these Streptococcus-like gram-positive cocci recovered from blood cultures of patients in a 6-year period.
The patients in this study were hospitalized at the Queen Mary Hospital in Hong Kong during a 6-year period (July 1995 to June 2001). All clinical data were collected prospectively. Clinical specimens were collected and handled according to standard protocols. The BACTEC 9240 blood culture system (Becton Dickinson, Sparks, Md.) was used. All suspect colonies were identified by standard conventional biochemical methods (9), and Streptococcus-like gram-positive cocci were further identified using the API system (20 STREP) (bioMerieux Vitek, Hazelwood, Mo.). 16S rRNA gene sequencing was used to confirm the identities of Granulicatella and Gemella (18, 19). MICs of penicillin, erythromycin, clindamycin, and vancomycin were determined by using the agar dilution method, and results were interpreted according to the NCCLS criteria for viridans streptococci (9, 10).
Bacterial DNA extraction and PCR amplification and DNA sequencing of the ermT, ermTR, ermB, and mef genes were performed according to our previous publications (7, 16, 20). The sequences of the PCR products were compared with known erm and mef gene sequences in GenBank by multiple sequence alignment using the CLUSTAL W program (14), and phylogenetic tree construction was performed using the PileUp method with GrowTree (Genetics Computer Group, Inc.).
The characteristics of the nine patients with bacteremia caused by Streptococcus-like gram-positive cocci (Granulicatella [n = 7] and Gemella [n = 2]) have been reported previously (18, 19). The MICs of the 11 Streptococcus-like gram-positive cocci isolates were summarized in Table 1. The isolates recovered from five patients (56%) (four Granulicatella adiacens isolates and one Gemella morbillorum isolate) were sensitive to penicillin, erythromycin, clindamycin, and vancomycin. One isolate of Gemella haemolysans was resistant to penicillin (MIC, 0.25 µg/ml) and erythromycin (MIC, 1 µg/ml), one G. adiacens isolate was resistant to penicillin (MIC, 0.25 µg/ml) and erythromycin (MIC, 8 µg/ml), and two G. adiacens isolates were resistant to erythromycin (MICs of 8 µg/ml for both isolates) but sensitive to penicillin, clindamycin, and vancomycin. All four Streptococcus-like gram-positive cocci isolates that were resistant to erythromycin possessed mef genes (Fig. 1), whereas none of them possessed ermT, ermTR, or ermB genes.
In our locality, erythromycin resistance in the prevalent alpha-hemolytic
and beta-hemolytic streptococci was mediated through
erm and/or
mef genes. For
Streptococcus pneumoniae, 27 and 73% of our erythromycin-resistant
isolates possessed
erm and
mef genes, respectively (
5). As for
Streptococcus bovis, recently we noticed that 24 (65%) out of
37
S. bovis strains isolated from patients with
S. bovis bacteremia
were erythromycin resistant (
7). Fourteen and 11 of these 24
erythromycin-resistant isolates possessed
ermB and
ermT genes,
respectively, with one isolate possessing both
ermB and
ermT genes, and none possessed
mef genes. For
Streptococcus pyogenes,
it was noticed that 36.5% of the isolates associated with invasive
S. pyogenes infections in our locality were resistant to erythromycin,
and the resistance was mediated through the possession of an
ermTR gene, a
mef gene, both an
ermTR and a
mef gene, or an
ermB gene (
2). As for beta-hemolytic Lancefield group G streptococci,
among 100 patients with beta-hemolytic group G streptococcal
bacteremia in a 6-year period, seven (7%) had bacteremia caused
by erythromycin-resistant beta-hemolytic group G streptococci
(
20). Five of the seven isolates possessed
mef genes only, whereas
one possessed an
ermTR gene and one possessed both
mef and
ermB genes. In contrast to
S. pneumoniae,
S. bovis,
S. pyogenes,
and beta-hemolytic group G streptococci, the present study showed
that erythromycin resistance in
Streptococcus-like gram-positive
cocci in our locality was mediated by the presence of
mef genes,
whereas none of the isolates possessed an
ermT,
ermTR, or
ermB gene. This observation of the presence of
mef genes but no
erm genes is in line with the phenotypic resistance profiles
of the isolates, in that all four isolates were resistant to
erythromycin but sensitive to clindamycin.
Macrolide resistance in Streptococcus-like as well as other gram-positive cocci may have resulted from horizontal transfer of mef genes, mainly among different species of gram-positive cocci (2, 4, 5, 8, 20). From the available sequence information, it can be observed that the mef genes of the three strains of G. adiacens and one strain of G. haemolysans shared more than 99% amino acid identities with those of S. pneumoniae (U83667, AF274302, AB011259, and AF376746), Streptococcus salivarius (AJ318993), Staphylococcus aureus (AY064721), Streptococcus intermedius (AY064722), an Enterococcus species (AY071836), and Streptococcus dysgalactiae (AY355410 and AY355408) (Fig. 1). These implied that there could be horizontal gene transfer of mef genes among the various gram-positive cocci. This is in line with the evidence from a study which showed that it is possible to move the mef gene from all 11 erythromycin-resistant S. pneumoniae isolates tested to erythromycin-susceptible S. pneumoniae and/or E. faecalis recipients (8). Since the mef genes of S. pneumoniae have been documented experimentally to be of the mef(E) type and that of S. pyogenes was of the mef(A) type (1), it is most likely that the mef genes of the four Streptococcus-like gram-positive cocci in the present study were of the mef(E) type, since their amino acid sequences shared more than 99% sequence identity with those of S. pneumoniae.
Nucleotide sequence accession numbers.
The mef gene sequences of the four Streptococcus-like gram-positive cocci iso-lates have been lodged within the GenBank sequence database under accession numbers AY422726, AY422727, AY422728, and AY422729.

ACKNOWLEDGMENTS
This work is partly supported by the University Development
Fund, University Research Grant Council, and the Committee for
Research and Conference Grant, The University of Hong Kong.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, Hong Kong, China. Phone: (852) 28554892. Fax: (852) 28551241. E-mail:
hkumicro{at}hkucc.hku.hk.


REFERENCES
1 - Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux gene mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.[Abstract/Free Full Text]
2 - Ho, P. L., D. R. Johnson, A. W. Y. Yue, D. N. C. Tsang, T. L. Que, B. Beall, and E. L. Kaplan. 2003. Epidemiologic analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong. J. Clin. Microbiol. 41:937-942.[Abstract/Free Full Text]
3 - Horinouchi, S., W. Byeon, and B. A. Weisblum. 1983. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J. Bacteriol. 154:1252-1262.[Abstract/Free Full Text]
4 - Ip, M., D. J. Lyon, T. Leung, and A. F. B. Cheng. 2002. Macrolide resistance and distribution of erm and mef genes among beta-haemolytic streptococci in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 21:238-240.[CrossRef][Medline]
5 - Ip, M., D. J. Lyon, R. W. H. Yung, C. Chan, and A. F. B. Cheng. 2001. Macrolide resistance in Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 45:1578-1580.[Abstract/Free Full Text]
6 - Kataja, J., H. Seppälä, M. Skurnik, H. Sarkkinen, and P. Huovinen. 1998. Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob. Agents Chemother. 42:1493-1494.[Abstract/Free Full Text]
7 - Lee, R. A., P. C. Y. Woo, A. P. C. To, S. K. P. Lau, S. S. Y. Wong, and K. Y. Yuen. 2003. Geographical difference of disease association in Streptococcus bovis bacteremia. J. Med. Microbiol. 52:903-908.[Abstract/Free Full Text]
8 - Luna, V. A., P. Coates, E. A. Eady, J. H. Cove, T. T. H. Nguyen, and M. C. Roberts. 1999. A variety of Gram-positive bacteria carry mobile mef genes. J. Antibicrob. Chemother. 44:19-25.
9 - Murray, P. R., E. J. Baro, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1999. Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
10 - National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6, 6th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11 - Reinert, R. R., R. Lutticken, A. Bryskier, and A. Al-Lahham. 2003. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob. Agents Chemother. 47:489-493.[Abstract/Free Full Text]
12 - Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.[Abstract/Free Full Text]
13 - Teng, L. J., P. R. Hsueh, S. W. Ho, and K. T. Luh. 2001. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob. Agents Chemother. 45:3362-3365.[Abstract/Free Full Text]
14 - Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.[Abstract/Free Full Text]
15 - Trieu-Cuot, P., C. Poyart-Salmeron, C. Carlier, and P. Courvalin. 1990. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res. 18:3660.[Free Full Text]
16 - Woo, P. C. Y., D. M. W. Tam, K. W. Leung, S. K. P. Lau, J. L. L. Teng, M. K. M. Wong, and K. Y. Yuen. 2002. Streptococcus sinensis sp. nov., a novel Streptococcus species isolated from a patient with infective endocarditis. J. Clin. Microbiol. 40:805-810.[Abstract/Free Full Text]
17 - Woo, P. C. Y., S. K. P. Lau, and K. Y. Yuen. 2002. Macrolides as immunomodulatory agents. Curr. Med. Chem. Anti-Inflamm. Anti-Allergy Agents 1:131-141.
18 - Woo, P. C. Y., A. M. Y. Fung, S. K. P. Lau, B. Y. L. Chan, S. K. Chiu, T. L. Que, R. W. H. Yung, and K. Y. Yuen. 2003. Granulicatella adiacens and Abiotrophia defectiva bacteraemia characterised by 16S rRNA gene sequencing. J. Med. Microbiol. 52:137-140.[Abstract/Free Full Text]
19 - Woo, P. C. Y., S. K. P. Lau, A. M. Y. Fung, S. K. Chiu, R. W. H. Yung, and K. Y. Yuen. 2003. Gemella bacteraemia characterised by 16S ribosomal RNA gene sequencing. J. Clin. Pathol. 56:690-693.[Abstract/Free Full Text]
20 - Woo, P. C. Y., A. P. C. To, H. Tse, S. K. P. Lau, and K. Y. Yuen. 2003. Clinical and molecular epidemiology of erythromycin-resistant beta-hemolytic Lancefield group G streptococci causing bacteremia. J. Clin. Microbiol. 41:5188-5191.[Abstract/Free Full Text]
21 - Wu, J. J., K. Y. Lin, P. R. Hsueh, J. W. Liu, H. I. Pan, and S. M. Sheu. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:844-846.[Abstract/Free Full Text]
Journal of Clinical Microbiology, July 2004, p. 3303-3305, Vol. 42, No. 7
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.7.3303-3305.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Zolezzi, P. C., Cepero, P. G., Ruiz, J., Laplana, L. M., Calvo, C. R., Gomez-Lus, R.
(2007). Molecular Epidemiology of Macrolide and Tetracycline Resistances in Commensal Gemella sp. Isolates. Antimicrob. Agents Chemother.
51: 1487-1490
[Abstract]
[Full Text]